Johnson & Johnson plans to invest $55 billion in the US to boost its manufacturing capacity and research and development. The investment is expected to include the creation of new manufacturing sites, although the exact number and locations are not consistently reported. Other pharmaceutical companies, including Bristol Myers Squibb, are also making significant investments in US manufacturing, possibly in response to potential tariffs.